BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
Suzhou, China – March 12–14, 2026 – The global biopharmaceutical industry will gather in Suzho...
March 12, 2026 - March 14, 2026London Biotechnology Show 2026
The London Biotechnology Show Returns: Bigger & Bolder for Its 3rd Edition! After two successful...
June 9, 2026 - June 10, 2026
Lupin Europe GmbH rounds off the year with a significant stride as the Committee for Medicinal Products for Human Use (CHMP) grants a positive opinion, recommending Ranluspec for marketing...
The European Medicines Agency (EMA) convened a pivotal meeting with stakeholders to address the future of pharmaceutical policies. Held both online and in-person, this first assembly of all qualifying...
Healthcare Policy and Regulation
Senegal Tackles Antibiotic Resistance with Comprehensive One Health Strategy
Senegal faces an escalating challenge as antibiotic resistance (ABR) increasingly endangers public health. This peril emerges from the intricate interplay of human, animal, and ecosystem health. Recent efforts in...
Clinical Researches
Glucarpidase Shows Promising Results in Methotrexate Elimination in Japanese Patients
Navigating the complexities of high-dose methotrexate (HD-MTX) therapy has always posed significant challenges, particularly in terms of toxicity and delayed MTX elimination. Researchers recently assessed the potential of glucarpidase,...
Upcoming Meetings
Pharmacoeconomics
Latest NewsLatest
CHMP Endorses Ranluspec for Vision-Related Disorders
Lupin Europe GmbH rounds off the year with a significant stride as the Committee for Medicinal Products for Human Use (CHMP) grants a positive...
New Insights into Seizure Classification at Secondary Epilepsy Clinics
In the ever-evolving landscape of epilepsy management, healthcare professionals continuously seek methods to enhance diagnosis precision and treatment effectiveness. A recent study sheds light...
Cost-Effectiveness of Embryo Transfer Strategies in IVF
In the evolving world of assisted reproductive technology, determining cost-efficient embryo transfer strategies remains a priority for optimizing clinical and economic outcomes. Recent insights...
BRIDGE Kicks Off Strategic Assembly in Brussels for Health Tech Innovation
Under the grandeur of Brussels' institutional legacy, a pivotal step has been embarked upon by the European BRIDGE project. This ambitious initiative formally started...
Innovative MURTI Care Model Advances Patient Empowerment
Amidst the challenges of mild upper respiratory tract infections (MURTIs), a new patient-centered care model emerges, presenting fresh strategies for effective management. These infections,...
EMA Meets with Stakeholders, Announces Future Plans for Medicines Accessibility
The European Medicines Agency (EMA) convened a pivotal meeting with stakeholders to address the future of pharmaceutical policies. Held both online and in-person, this...
FDA Approves New Oral Therapies for Gonorrhea Treatment
In a landmark development, the U.S. Food and Drug Administration (FDA) has expanded treatment options for gonorrhea by approving two new oral medications, Nuzolvence...
New Flu Drug OneDose Revolutionizes Treatment with Unique Mechanism
Maxching the anticipation of major pharmaceutical innovations, Healthy Yuan Pharmaceuticals has seen a notable development with the approval of Marpasisavir capsules (trade name: Yilikang®)...
Slovakia Addresses Requests for Medical Materials Inclusion
In Slovakia, the National Institute for Value and Technology in Healthcare (NIHO) takes a vital role by evaluating special medical materials for inclusion in...
North Carolina’s Medicaid Expansion Spurs Buprenorphine Prescriptions Amid Policy Changes
As Medicaid's continuous enrollment policy ended in March 2023, millions across the U.S. faced disenrollment, leading to concerns regarding access to essential treatments, including...
